File(s) under permanent embargo
Longitudinal assessment of neuropathy in type 1 diabetes using novel ophthalmic markers (LANDMark): Study design and baseline characteristics.
journal contribution
posted on 2014-05-01, 00:00 authored by N Pritchard, K Edwards, C Dehghani, H Fadavi, M Jeziorska, A Marshall, I Petropoulos, G Ponirakis, A Russell, Geoff SampsonGeoff Sampson, A Shahidi, S Srinivasan, M Tavakoli, D Vagenas, R Malik, N EfronLongitudinal assessment of neuropathy in type 1 diabetes using novel ophthalmic markers (LANDMark): Study design and baseline characteristics.
History
Journal
Diabetes research and clinical practiceVolume
104Issue
2Pagination
248 - 256Publisher
ElsevierLocation
Amsterdam, The NetherlandsPublisher DOI
ISSN
1872-8227eISSN
0168-8227Language
engPublication classification
C1.1 Refereed article in a scholarly journalCopyright notice
2014, ElsevierUsage metrics
Categories
No categories selectedKeywords
corneal confocal microscopydiabetic neuropathyLANDMark studylongitudinal trialnon-contact corneal aesthesiometryScience & TechnologyLife Sciences & BiomedicineEndocrinology & MetabolismEARLY NERVE REGENERATIONSMALL FIBER DAMAGEPERIPHERAL NEUROPATHYSENSORIMOTOR POLYNEUROPATHYRISK-FACTORSSENSITIVITYSEVERITYMULTICENTERDIAGNOSIS
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC